Profile data is unavailable for this security.
About the company
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Biovance 3L, CentaFlex, Interfyl and Rebound products.
- Revenue in USD (TTM)40.58m
- Net income in USD-80.71m
- Incorporated2018
- Employees123.00
- LocationCelularity Inc170 Park AveFLORHAM PARK 07932United StatesUSA
- Phone+1 (908) 768-2170
- Fax+1 (302) 636-5454
- Websitehttps://celularity.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TherapeuticsMD Inc | 2.80m | 73.00k | 27.32m | 1.00 | 378.21 | 0.9953 | 59.38 | 9.77 | 0.0062 | 0.0261 | 0.2419 | 2.37 | 0.0715 | -- | 0.8002 | 2,796,000.00 | 0.1867 | -42.65 | 0.2169 | -112.14 | -- | -- | 2.61 | -193.47 | -- | -5,240.00 | 0.00 | -- | 35.25 | -48.72 | 69.97 | -- | -- | -- |
| Kyntra Bio Inc | 8.30m | -131.13m | 30.14m | 225.00 | -- | -- | -- | 3.63 | -32.49 | 53.34 | 2.05 | -4.21 | 0.0413 | -1.47 | 0.421 | 36,880.00 | -64.00 | -39.47 | -260.98 | -61.33 | 345.69 | 90.21 | -1,548.18 | -199.02 | 3.60 | -- | 0.5269 | -- | -36.71 | -35.07 | 52.60 | -- | -45.94 | -- |
| United-Guardian Inc | 10.06m | 1.96m | 30.32m | 24.00 | 15.47 | 2.87 | 14.69 | 3.01 | 0.4266 | 0.4266 | 2.19 | 2.30 | 0.7911 | 3.82 | 7.58 | 419,180.40 | 15.41 | 26.91 | 17.85 | 31.16 | 50.60 | 54.16 | 19.48 | 26.97 | 6.16 | -- | 0.00 | 92.34 | 11.91 | -2.18 | 25.94 | -7.35 | 30.65 | -8.64 |
| SCYNEXIS Inc | 2.93m | -25.30m | 31.47m | 28.00 | -- | 0.8638 | -- | 10.73 | -0.5107 | -0.5107 | 0.0593 | 0.8683 | 0.0391 | -- | 0.5776 | 104,714.30 | -33.71 | -20.51 | -43.65 | -24.97 | 33.32 | -- | -862.89 | -64.82 | -- | -- | 0.00 | -- | -97.33 | 98.68 | -131.75 | -- | -- | -- |
| Healthy Extracts Inc | 3.59m | -1.17m | 33.74m | 2.00 | -- | 1.40 | -- | 9.40 | -0.3195 | -0.3195 | 0.9095 | 1.43 | 0.2505 | 1.42 | 140.67 | 1,794,555.00 | -8.19 | -61.21 | -9.09 | -111.60 | 52.37 | 51.30 | -32.71 | -82.01 | 0.6491 | -2.84 | 0.0421 | -- | 25.24 | 32.99 | 66.01 | -- | -- | -- |
| BioXcel Therapeutics Inc | 752.00k | -68.21m | 34.55m | 37.00 | -- | -- | -- | 45.95 | -10.41 | -10.41 | 0.1023 | -4.45 | 0.016 | 0.9718 | 501.33 | 20,324.32 | -145.62 | -76.45 | -449.90 | -88.28 | -28.19 | -- | -9,070.61 | -14,760.23 | 1.16 | -3.25 | 5.40 | -- | 64.20 | -- | 66.71 | -- | -- | -- |
| Hyperion DeFi Inc | 345.32k | -26.40m | 35.08m | 13.00 | -- | 0.4191 | -- | 101.58 | -20.32 | -20.32 | 0.0385 | 9.88 | 0.0065 | -- | 1.06 | 26,563.08 | -48.31 | -102.28 | -59.47 | -168.53 | -798.11 | 60.58 | -7,385.51 | -856.97 | -- | -- | 0.0976 | -- | 1,412.93 | -- | -82.75 | -- | -0.6271 | -- |
| Celularity Inc | 40.58m | -80.71m | 36.48m | 123.00 | -- | -- | -- | 0.899 | -3.34 | -3.34 | 1.69 | -0.7121 | 0.3339 | 6.14 | 5.24 | 329,902.40 | -66.35 | -23.42 | -158.76 | -26.83 | 50.61 | -- | -198.75 | -294.70 | 0.123 | -6.57 | 2.01 | -- | 138.11 | -- | 70.51 | -- | -- | -- |
| Telomir Pharmaceuticals Inc | 0.00 | -11.25m | 37.48m | -- | -- | 5.28 | -- | -- | -0.3739 | -0.3739 | 0.00 | 0.2063 | 0.00 | -- | -- | -- | -266.47 | -- | -303.19 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -26.48 | -- | -- | -- |
| Talphera Inc | 28.00k | -12.46m | 37.79m | 13.00 | -- | 1.93 | -- | 1,349.68 | -0.3808 | -0.378 | 0.0009 | 0.4207 | 0.0011 | -- | -- | 2,153.85 | -48.15 | -14.86 | -54.44 | -19.40 | -- | -- | -44,503.57 | -446.19 | -- | -- | 0.00 | -- | -100.00 | -- | -26.41 | -- | -- | -- |
| Earth Science Tech Inc | 33.84m | 2.81m | 37.88m | 76.00 | 14.08 | 7.61 | 12.26 | 1.12 | 0.0092 | 0.0092 | 0.1114 | 0.0171 | 4.93 | 12.73 | 156.99 | 445,269.50 | 40.56 | 24.04 | 66.31 | -- | 72.21 | 71.08 | 8.22 | 5.50 | 0.7202 | 7.06 | 0.009 | -- | 177.05 | 128.98 | 300.63 | -- | -- | -- |
| Rockwell Medical Inc | 75.58m | -5.48m | 39.80m | 244.00 | -- | 1.08 | -- | 0.5266 | -0.1583 | -0.1583 | 2.20 | 0.9395 | 1.32 | 12.92 | 8.78 | 309,741.80 | -9.63 | -32.92 | -12.15 | -46.61 | 15.81 | 8.00 | -7.30 | -23.86 | 3.50 | -6.13 | 0.2141 | -- | 21.38 | 10.61 | 94.31 | -- | 11.47 | -- |
| BioScience Health Innovations Inc | 4.73m | 885.68k | 43.92m | -- | 206.50 | 25.67 | -- | 9.29 | 0.0194 | 0.0194 | 0.1313 | 0.1558 | 3.81 | 4.30 | 99.37 | -- | 71.34 | -- | 85.11 | -- | 63.64 | -- | 18.74 | -- | 3.47 | -- | 0.00 | -- | 208.73 | -- | 134.59 | -- | -- | -- |
| Elutia Inc | 21.08m | -22.99m | 44.84m | 51.00 | -- | -- | -- | 2.13 | -0.6006 | -0.6827 | 0.5347 | -1.03 | 0.5419 | 4.04 | 6.50 | 413,411.80 | -59.08 | -57.79 | -- | -128.41 | 45.97 | 42.77 | -109.03 | -92.86 | 0.396 | -- | -- | -- | -1.50 | -10.69 | -31.23 | -- | 2.54 | -- |
| Zhengye Biotechnology Holding Ltd | 22.25m | -2.80m | 45.54m | 277.00 | -- | 1.05 | 134.80 | 2.05 | -0.059 | -0.059 | 0.4787 | 0.9131 | 0.3099 | 1.62 | 2.04 | 80,341.63 | -4.60 | -- | -7.79 | -- | 37.37 | -- | -14.83 | -- | 1.10 | -7.00 | 0.1902 | -- | -11.95 | -- | -64.04 | -- | -- | -- |
Data as of Feb 17 2026. Currency figures normalised to Celularity Inc's reporting currency: US Dollar USD
14.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Starr Investment Holdings LLCas of 30 Oct 2025 | 1.53m | 6.38% |
| C.V. Starr & Co., Inc.as of 31 Dec 2025 | 764.07k | 3.19% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 594.46k | 2.48% |
| Geode Capital Management LLCas of 31 Dec 2025 | 160.19k | 0.67% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 112.70k | 0.47% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 79.87k | 0.33% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 57.83k | 0.24% |
| Valmark Advisers, Inc.as of 31 Dec 2025 | 49.98k | 0.21% |
| Citadel Securities LLCas of 30 Sep 2025 | 44.76k | 0.19% |
| Jane Street Capital LLCas of 31 Dec 2025 | 41.31k | 0.17% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
